Volume 2014:Article ID 958621 | Vergara-Jimenez M, Almatrafi MM, Fernandez ML
5 Likewise, research published in 2024 indicates that semaglutide approximately doubles NAION risk, albeit with a very low absolute incidence, emphasizing the need for clinicians and patients to remain vigilant
- ,
Furthermore, the total amount of gastrointestinal retained hydrogen in the Si group, excluding the cecum, was higher than that in the control group
Besides the primary endpoints of death, heart attack, and stroke, the study also examined secondary outcomes such as how much the drug lowered blood levels of known risk factors for heart disease
Hear from people who make ARMRA part of their daily gut, hair, skin, energy, and recovery routine.* GUT SUPPORT RITUAL "This product is life changing effecting my entire body